Federal Law ‘On Biomedical Cell Products'
20 July 2016
To print this article, all you need is to be registered or login on Mondaq.com.
The Federal Law No. 180-FZ dated 23 June 2016 'On Biomedical
Cell Products' is aimed at developing the sector of biomedical
technologies in Russia.
The Law has been developed with a view of the best international
practices and regulates relations in connection with the
development, pre-clinical trials, expertise, state registration,
clinical trials, production, sale, storage, transportation, use,
destruction, import in and export from the Russian Federation of
biomedical cell products for the prevention, diagnosing and
treatment of diseases (states), pregnancy maintenance and medical
rehabilitation of a patient, as well as in connection with the
donation of biological material for the production of biomedical
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from Russian Federation
Drug Laws In Italy
Arnone & Sicomo
Drug laws in Italy: Everything you need to know about drugs and which ones are decriminalized.
Rules On Controlled Substances
Law 9/2023 ("Law 9/2023") was published on 3 March and it introduces the following amendments to Decree-Law 15/93 of 22 January 1993.
Trending In Telehealth: February 27 – March 5, 2023
McDermott Will & Emery
Trending in Telehealth is a new series from the McDermott Digital Health team in which we highlight state legislative and regulatory developments that impact the healthcare providers, telehealth and digital health companies, pharmacists, and technology companie.